Clinical Trial Update: Palliative Care Oncology in Patients With Relapsed, Refractory, and High-Risk Leukemias or MDS [Phase 2]

View source ↗

Summary

This clinical trial update describes a Phase 2 study evaluating palliative care oncology in adults with relapsed, refractory, or high-risk acute leukemias and m…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia
• Acute Myeloid Leukemia
• Myelodysplastic Syndrome

Snippet

Sponsor: University of Virginia | Conditions: Leukemia, Acute, AML, Adult | Phase 2 | Status: ACTIVE_NOT_RECRUITING